US biotech major Gilead Sciences was trading nearly 5% higher in Wednesday’s pre-market trading after presenting its fourth ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

The latest ASX small and microcap health news covering everything from drug and biotech developments to medical devices and medicinal cannabis.

Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) had its price objective decreased by JMP Securities from $23.00 to $14.00 in a research note issued to investors on Thursday morning,Benzinga ...

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) shares reached a new 52-week low during trading on Friday after JMP Securities lowered their price target on the stock from $23.00 to $14 ...

Biotech stocks are companies that use living organisms to make drugs and vaccines. Often, they merge cutting-edge technology with new findings in molecular science and virology to treat life ...

AbbVie (ABBV) stock was one of the top gainers in the S&P 500 Friday morning as the biotech firm posted better-than-expected sales and gave strong guidance on higher demand for two of its drugs to ...

Let's take a look at the biotech stocks awaiting FDA decisions in February. Supernus Pharmaceuticals Inc. (SUPN) The FDA decision on Supernus Pharma's SPN-830, an investigational apomorphine ...

A live webcast of the fireside chat can be accessed through the Investors & Media section of the Company’s website at https://investors.vaxcyte.com. A replay of the webcast will be available for ...

Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...